巵柤丗丂媨棦 抭巕乮傒傗偞偲 偲傕偙乯
亂妛弍榑暥亃(嵏撉偁傝乯
仭2017擭乮暯惉29擭乯
1.媨棦抭巕, 媨忛湪巕, 暯椙岶旤, 摽椾宐旤: 昦堾娕岇晹栧偵偍偗傞栚昗娗棟偵娭偡傞暥專専摙. 壂撽導棫娕岇戝妛婭梫, 18,29-33, 2017.
2.幱壴彫昐崌, 媨棦抭巕, 夑悢偄偯傒, 揷応桼婭, 嵒愳備偐傝, 戝榩柧旤: 娕岇妛巑壽掱偵偍偗傞媞娤揑椪彴擻椡帋尡傊偺妛惗偺庢傝慻傒丏壂撽導棫娕岇
戝妛婭梫,丂18, 61-66. 2017.
仭2016擭乮暯惉28擭乯
1. 媨棦抭巕, 戝愳椾巕, 夑悢偄偯傒, 惣暯朁巕, 杚撪擡, 埳椙攇棟奊: 椪抧幚廗偵偍偗傞妛惗偺娕岇椣棟偵娭偡傞懱尡, 壂撽導棫娕岇戝妛婭梫,
17, 79-87, 2016.
仭2015擭乮暯惉27擭乯
1. 戝榩柧旤, 嵅媣愳惌媑, 拠廆崻梞巕, 夑悢偄偯傒, 忋尨榓戙, 杚撪擡, 媨棦抭巕, 嶳岥弶戙: 搰涀抧堟偲搒巗抧堟偺娕岇怑幰偺恖帠岎棳偵傛傞僉儍儕傾傾僢僾儌僨
儖奐敪乮戞侾曬乯 摉帠幰偑懆偊傞壽戣偲夝寛曽朄, 壂撽導棫娕岇戝妛婭梫, 16, 117-124, 2015.
仭2014擭乮暯惉26擭乯
1. 恄棦傒偳傝, 慜揷榓巕, 愒椾埳搒巕, 揷応桼婭, 幱壴彫昐崌, 媨棦抭巕, 嬥忛擡, 忋尨榓戙, 壝庤姟塸巕丗妛廗幰庡懱偺嫵堢媄朄偺廋摼偵岦偗
丂 偨慡妛揑側庢傝慻傒, 壂撽導棫娕岇戝妛嫵堢幚慔婭梫, 1(1), 1-7, 2014.
2. 壝庤姟塸巕, 嬥忛擡, 媨棦抭巕, 崅嫶岾巕, 埳椙攇棟奊丗婛廗娕岇媄弍偺10偐寧屻偵偍偗傞妛惗偺媄弍廋摼忬嫷亅塮憸婰榐傪梡偄偨夌彴姵
丂 幰偺幵偄偡堏摦媄弍偺昡壙偐傜, 壂撽導棫娕岇戝妛婭梫, 15, 77-85, 2014.
仭2013擭乮暯惉25擭乯
1. 媨棦抭巕,埳椙攇棟奊,崅嫶岾巕,嬥忛擡,壝庤姟塸巕丗擔杮崙撪偺娕岇婎慴嫵堢偵偍偗傞僨傿儀乕僩偺庢傝慻傒偵娭偡傞暥專専摙,庢傝慻傒偺
幚嵺偲嫵堢岠壥偍傛傃壽戣, 壂撽導棫娕岇戝妛婭梫, 戞14崋, 81-88, 2013.
仭2011擭乮暯惉23擭乯
1.戝忛扖摽, 柤搉嶳抭巕丗HIV姶愼徢姵幰偵愱擟偱偐偐傢傞娕岇巘偺HIV姶愼徢姵幰偺娕岇偵懳偡傞峫偊偲巔惃.
擔杮姶愼娕岇妛夛帍,7(1), 18-25, 2011.
2.拠廆崻桼旤, 柤搉嶳抭巕丗僞僋僔乕忔柋堳偺屇媧婍姶愼徢梊杊偺尰忬. 娐嫬姶愼帍, 26(3), 167-171, 2011.
仭2008擭乮暯惉20擭乯
1. 拠廆崻梞巕, 柤搉嶳抭巕: 娕岇巘偺庤彾偍傛傃旲峯偵偍偗傞栻嵻懴惈嬠偺専弌昿搙, 壂撽導棫娕岇戝妛婭梫, 9, 39-43, 2008.
仭2007擭乮暯惉19擭乯
1. 柤搉嶳抭巕, 拠廆崻梞巕 : 娕岇妛惗偺姶愼杊巭偵娭偡傞棟夝偲椪抧幚廗偵偍偗傞姶愼杊巭懳嶔偺幚巤忬嫷, 娐嫬姶愼.24.163-168. 2007.
2. 柤搉嶳抭巕, 戝忛桽庽, 拠廆崻梞巕: A導撪3憤崌昦堾偵偍偗傞MRSA姶愼姵幰偺妘棧偺尰忬, 戞38夞擔杮娕岇妛夛榑暥廤, 277-279, 2007.
仭2005擭乮暯惉17擭乯
1.Tamaki Y., Natimatsu H., Miyazato T., Nakasone N., Higa N., Toma C. and Iwanaga M. : The relationship between O-antigen and pathogenic genes of diarrhea-associated Escherichia coli.Jpn.J. Infect. Dis.58. 65-69.2005.
仭2004擭乮暯惉16擭乯
1. Higa N., Sithivong N., Phantouamath B., Insisiengmay S., Miyazato T. and Iwanaga M.: Initial stage of hospital contamination with methicillin-resistant Staphylococcus aureus in Lao People’s Democratic Republic. J. Hosp. Infect. 56. 125-130. 2004.
2. Iwanaga M., Toma C., Miyazato T., Insisiengmay S., Nakasone N. and Ehara M.: Antibiotic resistance conferred by a class I integron and SXT constin in Vibrio cholerae O1 strains in Laos. Antimicrob. Agents Chemother
3. Miyazato T., Tamaki Y., Sithivong N., Phantouamath B., Insisiengmay S., Higa N., Toma C., Nakasone N. and Iwanaga M. :Antibiotic susceptibility and its genetic analysis of Vibrio cholelae non-O1, non-O139 from environmental source in Lao People’s Democratic Republic. Tropical Medicine and health.32. 245-248. 2004.
仭2003擭乮暯惉15擭乯
1. 丂Miyazato T., Toma C., Nakasone N., Yamamoto K. and Iwanaga M. : Molecular analysis of VcfQ protein involved in Vibrio cholerae type IV pilus biogenesis.
J. Med. Microbiol.54.283-288. 2003.?48.2364-2369. 2004.
亂曬崘彂亃
仭2012擭乮暯惉23擭乯
1.埨扟壆嬒丄抮揷柧巕丄壼柤旤抭巕丄戝愳椾巕丄戝榩柧旤丄壝庤姟塸巕丄愳嶈摴巕丄嬥忛朏廏丄彫抮廏巕丄嵅媣愳惌媑丄嬍忛惔巕丄拠廆崻梞巕丄媨棦抭巕
乮2012擭乯暯惉24擭搙丂愱栧揑娕岇巘丒栻嵻巘摍堛椕恖嵽梴惉帠嬈丂搰偟傚偵偍偗傞乽曪妵揑愱栧娕岇巘乿偺梴惉丂乕乽嫵堢僇儕僉儏儔儉奐敪偵傛傞栶妱奼戝乿偺嫵堢僾儘僌儔儉乕暯惉24擭搙丂惉壥曬崘彂
亂妛夛敪昞亃
仭2015擭乮暯惉27擭乯
1. 媨棦抭巕, 媨忛湪巕, 抦擮媣旤巕, 埳椙攇棟奊: 彫棧搰恌椕強娕岇巘偺娕岇娗棟偵娭偡傞栶妱, 戞19夞傊偒抧丒棧搰媬媫堛椕妛夛妛弍廤夛
乣棧搰堛椕偺枹棃傪扵傞乣丆p50丆2015.
2. 媨忛湪巕, 媨棦抭巕, 抦擮媣旤巕, 埳椙攇棟奊: 彫棧搰恌椕強娕岇巘偺娕岇娗棟偺幚懺偲擻椡, 戞35夞擔杮娕岇壢妛妛夛妛弍廤夛, 2015.
仭2014擭乮暯惉26擭乯
1. 媨棦抭巕丄埳椙攇棟奊丄杚撪擡丄戝愳椾巕丄夑悢偄偯傒丄拠廆崻梞巕丄惣暯朁巕乮2014擭11寧乯娕岇妛惗傪懳徾偲偟偨娕岇椣棟嫵堢偺偨傔偺帠椺偺榞慻傒偺専摙, 戞34夞擔杮娕岇壢妛妛夛丄垽抦
仭2012擭乮暯惉23擭乯
1.壝庤姟塸巕丄嬥忛擡丄媨棦抭巕丄崅嫶岾巕丄埳椙攇棟奊乮2012擭11寧乯丄愊傒廳偹偵傛傞婛廗媄弍偺廋摼忬嫷偺曄壔丄堏摦媄弍 偺帺屓價僨僆僠僃僢僋寢壥偺宱帪揑 斾妑偐傜, 戞32夞擔杮 娕岇壢妛妛夛丄愮戙揷嬫
2. 拞搱宐旤巕丄捤尨傂偲傒丄媑抾旤嵅巕丄徏壀椢丄堫奯對戙丄墶愳桾旤巕丄愇愳岾戙丄嶁堜朚巕丄?杮榓戙丄惗栰斏巕丄壝庤姟塸巕丄媨棦抭巕丄嵒愳梞巕丄徠壆揟巕丄媀娫宲巕丄徏堜憦巕丄丂 杒愳柧丄徏塝尗挿丄埨巁巎巕乮2012擭11寧乯椪抧幚廗巜摫幰尋廋夛嶲壛屻偺擣幆丒島摪偺曄壔, 嬨廈壂撽娕岇宯14戝妛偵傛傞働傾儕儞僌CSD偺幚慔丄戞32夞擔杮娕岇壢妛妛夛丄愮戙揷嬫
3. 搶棖嵷丄媨棦抭巕乮2013擭3寧乯丗椪抧幚廗婜娫拞偺娕岇妛惗偵偍偗傞怴宆僀儞僼儖僄儞僓(A/H1N1)偵懳偡傞梊杊堄幆偲峴摦丄戞28夞擔杮娐嫬姶愼妛夛憤夛丄墶昹巗
4. 媨棦抭巕乮2013擭3寧乯丗堦斒恌椕強偵廇嬈偡傞娕岇巘偺姶愼梊杊娕岇媄弍偵娭偡傞妛廗僯乕僘丄 戞28夞擔杮娐嫬姶愼妛夛憤夛丄墶昹巗
仭2011擭乮暯惉22擭乯
侾.拠媑敧廳, 怴忛僩儓, 媨棦垽巕, 揷岾崄戙, 柤搉嶳抭巕: 敧廳嶳昦堾偺曄慗偲娕岇妶摦,
擔杮娕岇楌巎妛夛 戞25夞妛弍廤夛. 壂撽, 2011擭8寧丂丂丂丂丂丂丂丂丂丂丂丂丂丂丂丂丂丂丂丂丂
亂奜晹帒嬥偱偺尋媶旓妉摼亃
1. 暯惉28擭乣暯惉30擭丂壢妛尋媶旓彆惉帠嬈乮妛弍尋媶彆惉婎嬥彆惉嬥乯乮婎斦尋媶乮俠乯丂尋媶戙昞幰
丂丂彫棧搰偱妶桇偡傞崅搙幚慔娕岇巘偺働傾偲僉儏傾傪梈崌偟偨幚廗僾儘僌儔儉偺峔抸
2. 暯惉26擭乣暯惉28擭丂 壢妛尋媶旓彆惉帠嬈乮妛弍尋媶彆惉婎嬥彆惉嬥乯乮婎斦尋媶乮C乯乯丂尋媶暘扴幰
丂丂娕岇婎慴嫵堢壽掱偵偍偗傞摑崌幚廗偺昡壙婎弨峔抸偵岦偗偨幚慔帠椺偺嶌惉
3. 暯惉21擭乣22擭丂壢妛尋媶旓曗彆嬥乮庒庤尋媶乮B)乯 尋媶戙昞幰
丂 堦斒恌椕強偵廇嬈偡傞娕岇巘偺姶愼梊杊娕岇媄弍偵娭偡傞娕岇宲懕嫵堢僾儘僌儔儉偺
専摙.丂
